×
News Home

Is Cara Therapeutics Inc (CARA) Stock a Smart Value Monday?

Monday, January 10, 2022 03:32 PM | InvestorsObserver Analysts
Is Cara Therapeutics Inc (CARA) Stock a Smart Value Monday?

The 43 rating InvestorsObserver gives to Cara Therapeutics Inc (CARA) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 87 percent of stocks in the Healthcare sector, CARA’s 43 overall rating means the stock scores better than 43 of all stocks.

Overall Score - 43
CARA has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on CARA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 43 would rank higher than 43 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cara Therapeutics Inc Stock Today?

Cara Therapeutics Inc (CARA) stock has risen 2.04% while the S&P 500 is lower by -0.79% as of 3:32 PM on Monday, Jan 10. CARA has risen $0.24 from the previous closing price of $11.76 on volume of 382,859 shares. Over the past year the S&P 500 is higher by 22.12% while CARA is lower by -26.92%. CARA earned $0.44 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 27.36. Click Here to get the full Stock Report for Cara Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App